Metastases Clinical Trials in Guangzhou, Guangdong
10 recruitingGuangzhou, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Brain MetastasesLung AdenocarcinomaWhole-Brain Radiotherapy+2 more
Sun Yat-sen University220 enrolled3 locationsNCT07481786
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.800 enrolled34 locationsNCT07143045
Recruiting
Phase 2
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.210 enrolled1 locationNCT07028268
Recruiting
Phase 3
FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma
Multiple Brain Metastases in Lung Adenocarcinoma
Sun Yat-Sen University Cancer Center258 enrolled1 locationNCT07058428
Recruiting
Phase 2
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases
Non-small Cell Lung CancerToxicityAdaptive Radiotherapy+2 more
Sun Yat-sen University130 enrolled1 locationNCT06542159
Recruiting
Phase 2
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Breast Cancer Brain Metastases
Shanghai Pharmaceuticals Holding Co., Ltd52 enrolled25 locationsNCT05872347
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
Circulating Tumor CellNasopharyngeal CarcinomaEffects of Chemotherapy+1 more
Sun Yat-sen University50 enrolled1 locationNCT04544969
Recruiting
Phase 2
Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study
Non-small Cell Lung Cancer (NSCLC)Leptomeningeal MetastasesBrain Metastases+2 more
Li-kun Chen70 enrolled1 locationNCT06728865
Recruiting
Not Applicable
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
SurgeryLung CancerSpinal Metastases+2 more
Guangdong Provincial People's Hospital118 enrolled1 locationNCT06244264
Recruiting
Not Applicable
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
Prostate Cancer With ≤10 Bone Metastases
Zhujiang Hospital30 enrolled1 locationNCT05740488